Work

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study

Year: 2001

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/sj.leu.2402077

Authors: S Trudel, Z Li, C Dodgson, S Nanji, Y Wan, M Voralia, M Hitt, J Gauldie, FL Graham, AK Stewart

Institutions: Princess Margaret Cancer Centre, McMaster University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2322831770

FWCI: 2.153

Cites: 35

Cited by: 38

Related to: 10